Rosh Dias's most recent trade in Spruce Biosciences Inc was a trade of 75,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 16, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Spruce Biosciences Inc | Rosh Dias | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2021 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
Spruce Biosciences Inc | Rosh Dias | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2021 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
Spruce Biosciences Inc | Rosh Dias | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 27,500 | 27,500 | - | - | Stock Option (Right to Buy) |